ScholarIQanswers from OpenAlex & ORCID
Constantine S. Mitsiades
ResearcherPublications, citations & collaboration network
Constantine S. Mitsiades is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Constantine S. Mitsiades have?
ScholarIQindexed works
Constantine S. Mitsiades has 648 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Constantine S. Mitsiades have?
ScholarIQcitation count
Constantine S. Mitsiades has 34,266 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Constantine S. Mitsiades?
ScholarIQh-index
Constantine S. Mitsiades has an h-index of 87 in OpenAlex.
What is the i10-index of Constantine S. Mitsiades?
ScholarIQi10-index
Constantine S. Mitsiades has an i10-index of 234 in OpenAlex.
What is the ORCID of Constantine S. Mitsiades?
ScholarIQorcid
The ORCID for Constantine S. Mitsiades is on the source record.
What is the OpenAlex record for Constantine S. Mitsiades?
ScholarIQopenalex
The OpenAlex for Constantine S. Mitsiades is on the source record.
What are the most-cited papers on Constantine S. Mitsiades?
ScholarIQmost cited works
Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
Paul G. Richardson, Edie Weller, Sagar Lonial, Andrzej Jakubowiak, Sundar Jagannath, Noopur Raje, David Avigan, Wanling Xie, Irene M. Ghobrial, Robert Schlossman, Amitabha Mazumder, Nikhil C. Munshi, David H. Vesole, Robin Joyce, Jonathan L. Kaufman, Deborah Doss, Diane Warren, Laura Lunde, Sarah Kaster, Carol Delaney, Teru Hideshima, Constantine S. Mitsiades, Robert Knight, Dixie‐Lee Esseltine, Kenneth C. Anderson
Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma
Paul G. Richardson, Robert Schlossman, Edie Weller, Teru Hideshima, Constantine S. Mitsiades, Faith E. Davies, Richard LeBlanc, Laurence Catley, Deborah Doss, Kathleen Kelly, Mary McKenney, Julie Mechlowicz, Andrea Freeman, Reggie Deocampo, Rebecca L. Rich, Joan J. Ryoo, Dharminder Chauhan, Kathe Balinski, Jerome B. Zeldis, Kenneth C. Anderson
A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma
Paul G. Richardson, Emily Blood, Constantine S. Mitsiades, Sundar Jagannath, Steven R. Zeldenrust, Melissa Alsina, Robert Schlossman, S. Vincent Rajkumar, K.R. Desikan, Teru Hideshima, Nikhil C. Munshi, Kathleen Kelly-Colson, Deborah Doss, Mary McKenney, Svetlana G. Gorelik, Diane Warren, Andrea Freeman, Rebecca L. Rich, Anfang Wu, Marta Olesnyckyj, Kenton Wride, William S. Dalton, Jerome B. Zeldis, Robert Knight, Edie Weller, Kenneth C. Anderson
Bortezomib induces canonical nuclear factor-κB activation in multiple myeloma cells
Teru Hideshima, Hiroshi Ikeda, Dharminder Chauhan, Yutaka Okawa, Noopur Raje, Klaus Podar, Constantine S. Mitsiades, Nikhil C. Munshi, Paul G. Richardson, Ruben D. Carrasco, Kenneth C. Anderson